The one-stop solution of automatic clinical mass spectrometry leads the new direction of clinical detection in the future
Inputtime：2019-03-27 15:17:00 Views：
The grass is green, the flowers are fragrant, and the city of nanchang is full of spring.
On March 21, more than 300 representatives of IVD manufacturers, dealers, inspection department directors and other professionals gathered at nanchang shangri-la hotel to attend the "rapid growth solutions for in vitro diagnostic manufacturers" nanchang station.
The event, the biological together nine IVD outstanding enterprises, and the participating experts and representatives of IVD policy environment what is discussed, in the next few years dealers how to transform, the latest development of IVD products market trends, industry contacts, such problems as how to build, condensed the academic consensus, a total of haocha, explore new future industry development and the current situation with IVD manufacturers to develop new ideas.
At the beginning of the meeting, Mr. Li guangyu, founder of in vitro diagnostic network, made a speech and Shared with us.
In the wonderful sharing and exchange session, Dr. Yanhui liu, a visiting scholar from Harvard University, was invited by yingsheng biology to give a lecture on "one-stop solution of automatic clinical mass spectrometry".
Dr. Liu introduced that mass spectrometry has the characteristics of high sensitivity, high specificity and high throughput, which can provide more accurate information for clinical diagnosis and treatment, and is an important development direction of clinical testing.
Currently, LC MS/MS is the most widely used mass spectrometry technology in clinical diagnosis, which is mainly applied to vitamin detection, therapeutic drug monitoring, neonatal genetic and metabolic disease screening, hormone detection, amino acid and bile acid detection, etc.
As a leader in the development and service of domestic clinical mass spectrometry technology, yingsheng biological co., ltd. has established international strategic cooperation with Thermo Fisher and Biotage to complement each other, and is committed to creating a one-stop solution of automation, process, intelligence and standardization of clinical mass spectrometry in China, which is of great significance for clinical diagnosis and treatment.
Dr Liu said that the British sheng biology major product lines include independent innovation development of deafness gene detects series reagent kit, 45 newborn genetic metabolic disease screening, 14 vitamins determination reagent, HLA B27 detection kits, mass spectrum automatic intelligent processing platform, the ultra high performance liquid chromatography tandem mass spectrometry detection system, etc., is a very good mass spectrometry leader.
Building 12, No. 1777, Dazheng Road, High-tech Zone, Jinan City
www.ivdys.com
0531-55561690
0531-55701378-8004
